Synopsys R&D decreased by 4.3% to $714.99M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 29.2%, from $553.22M to $714.99M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 13.3% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026Feb 25, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $362.35M | $371.15M | $413.86M | $383.97M | $389.96M | $444.83M | $371.09M | $465.33M | $460.46M | $484.47M | $465.82M | $525.53M | $493.14M | $508.87M | $554.82M | $553.22M | $553.98M | $625.30M | $746.84M | $714.99M |
| QoQ Change | — | +2.4% | +11.5% | -7.2% | +1.6% | +14.1% | -16.6% | +25.4% | -1.0% | +5.2% | -3.9% | +12.8% | -6.2% | +3.2% | +9.0% | -0.3% | +0.1% | +12.9% | +19.4% | -4.3% |
| YoY Change | — | — | — | — | +7.6% | +19.9% | -10.3% | +21.2% | +18.1% | +8.9% | +25.5% | +12.9% | +7.1% | +5.0% | +19.1% | +5.3% | +12.3% | +22.9% | +34.6% | +29.2% |
Range$362.35M – $746.84M
CAGR+15.4%
Avg YoY Growth+15.0%
Median YoY Growth+15.5%
R&D at Other Companies
Frequently Asked Questions
- What is Synopsys's r&d?
- Synopsys (SNPS) reported r&d of $714.99M in Q4 2025.
- How has Synopsys's r&d changed year-over-year?
- Synopsys's r&d increased by 29.2% year-over-year, from $553.22M to $714.99M.
- What is the long-term trend for Synopsys's r&d?
- Over 4 years (2021 to 2025), Synopsys's r&d has grown at a 13.3% compound annual growth rate (CAGR), from $1.50B to $2.48B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.